Pegylated Interferon-based Treatment Improves Response Rates in Immune-tolerant Patients with Chronic Hepatitis B: A Prospective Trial
The optimal management strategy for adults with immune-tolerant (IT) chronic hepatitis B infection remains undefined. This study aimed to investigate the efficacy and predictive factors of a pegylated interferon (Peg-IFN)-based treatment strategy in IT patients with chronic HBV infection.
Authors
- Bing Bu (ORCID: https://orcid.org/0000-0001-9469-5234)
- An Xiao
- Xiuying Ma
- Min Liu
- Ling Zhu
- Yilan Wang
- Yuting Zhang
- Wei Yue
- Lili Zuo
- Jiawei Geng
Publication Details
- Journal
- Journal of Clinical and Translational Hepatology
- Published
- 2026-03-31
- DOI
- https://doi.org/10.14218/jcth.2025.00712
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kunming University of Science and Technology